半夏泻心汤含药肠吸收液通过干预TA-BMSCs中SDF1-CXCR4轴抑制胃癌细胞侵袭迁移OA
Banxia Xiexintang Containing Intestinal Absorption Solution Inhibits Gastric Cancer Cell Invasion and Migration by Modulating SDF1-CXCR4 Axis in TA-BMSCs
目的:探讨半夏泻心汤含药肠吸收液是否通过干预肿瘤相关骨髓间充质干细胞(TA-BMSCs)中基质细胞衍生因子1(SDF1)-CXC趋化因子受体4(CXCR4)轴,抑制胃癌细胞的侵袭与迁移.方法:制备半夏泻心汤含药肠吸收液并采用细胞增殖与活性检测(CCK-8)法筛选其对小鼠前胃癌细胞(MFC)的最佳干预浓度及时间.采用 TA-BMSCs 条件培养基(TA-BMSCs-CM)与胃癌细胞 MFC 共培养体系,设立空白组、TA-BMSCs-CM 组、SDF1抑制剂(LY2510924)组及不同浓度(55%、70%、85%)半夏泻心汤含药肠吸收液干预组.通过CCK-8法检测细胞增殖,划痕实验与Transwell实验分别检测细胞横向与纵向迁移,Transwell(含基质胶)实验检测细胞侵袭,流式细胞术检测细胞凋亡,酶联免疫吸附测定法(ELISA)与蛋白免疫印迹法(Western blot)分别检测SDF1、基质金属蛋白酶-9(MMP-9)、抗血管内皮生长因子A(VEGFA)等因子含量及巨噬细胞移动抑制因子(MIF)、CXCR4、VEGFA、MMP-9等蛋白表达.结果:CCK-8法结果显示,与干预24 h比较,干预48 h时各浓度的半夏泻心汤含药肠吸收液对MFC的抑制率均有显著升高(P<0.01).半夏泻心汤含药肠吸收液在48 h干预MFC的半数抑制浓度(IC50)为 68.51%,后续选择干预浓度为 55%、70%、85%.与 TA-BMSCs-CM 组比较,半夏泻心汤含药肠吸收液(尤以70%和85%浓度)明显抑制MFC增殖、迁移与侵袭,促进细胞凋亡(P<0.05,P<0.01),并明显下调SDF1、MMP-9、VEGFA等因子水平及MIF、CXCR4、VEGFA、MMP-9蛋白表达(P<0.05,P<0.01),其作用显著优于或相当于SDF1抑制剂(P<0.01).结论:半夏泻心汤含药肠吸收液可通过干预TA-BMSCs中SDF1-CXCR4轴,抑制胃癌细胞的侵袭与迁移,其机制可能与调控MIF/SDF1/CXCR4信号通路及下游效应分子有关.
Objective:To explore whether the intestinal absorption solution containing Banxia Xiexintang(BXT)can inhibit the invasion and migration of gastric cancer cells by interfering with the stromal cell-derived factor 1(SDF1)-CXC chemokine receptor 4(CXCR4)axis in tumor-associated bone marrow mesenchymal stem cells(TA-BMSCs).Methods:The intestinal absorption solution containing BXT was prepared,and the optimal intervention concentration and duration for MFC cells were determined through the cell counting kit-8(CCK-8)assay.A co-culture system was established comprising TA-BMSCs conditioned medium(TA-BMSCs-CM)and gastric cancer MFC cells.The experiment was conducted with a blank control group,a TA-BMSCs-CM group,an SDF1 inhibitor(LY2510924)group,and intervention groups with varying concentrations(55%,70%,85%)of the intestinal absorption solution containing BXT.Cell proliferation was assessed by the CCK-8 assay.Horizontal and vertical cell migration were evaluated via scratch and Transwell assays,respectively.Cell invasion was examined by a Transwell assay with Matrigel.Cell apoptosis was detected by flow cytometry.The levels of factors such as SDF1,matrix metalloproteinase-9(MMP-9),and vascular endothelial growth factor A(VEGFA),as well as the protein levels of macrophage migration inhibitory factor(MIF),CXCR4,VEGFA,and MMP-9,were quantified by ELISA and Western blot,respectively.Results:The CCK-8 assay results indicated that compared with the 24 h intervention,the 48 h interventions with all concentrations of the intestinal absorption solution containing BXT increased the inhibition rate on MFC cells(P<0.01).The half-maximal inhibitory concentration(IC50)of the intestinal absorption solution containing BXT at the time point of 48 h was 68.51%,and subsequent intervention concentrations were selected as 55%,70%,and 85%.Compared with the TA-BMSCs-CM group,the intestinal absorption solution containing BXT(particularly at concentrations of 70%85%)suppressed the proliferation,migration,and invasion of MFC cells,promoted the cell apoptosis(P<0.05,P<0.01),decreased the levels of SDF1,MMP-9,and VEGFA,and downregulated the protein levels of MIF,CXCR4,VEGFA,and MMP-9(P<0.05,P<0.01).The inhibitory effects of the intestinal absorption solution containing BXT were comparable to or superior to those of the SDF1 inhibitor(P<0.01).Conclusion:The intestinal absorption solution containing BXT can inhibit the invasion and migration of gastric cancer cells by interfering with the SDF1-CXCR4 axis in TA-BMSCs.The underlying mechanism may involve the regulation of the MIF/SDF1/CXCR4 signaling pathway and its downstream effector molecules.
朱中博;杨文英;魏晶晶;李芳妮;施丽娟;刘喜平
甘肃中医药大学 甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药新产品创制工程实验室,兰州 730000甘肃中医药大学 甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药新产品创制工程实验室,兰州 730000甘肃中医药大学 甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药新产品创制工程实验室,兰州 730000甘肃中医药大学 甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药新产品创制工程实验室,兰州 730000甘肃中医药大学 甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药新产品创制工程实验室,兰州 730000甘肃中医药大学 甘肃省中医方药挖掘与创新转化重点实验室,甘肃省中药新产品创制工程实验室,兰州 730000
医药卫生
半夏泻心汤含药肠吸收液肿瘤相关骨髓间充质干细胞细胞串话
Banxia Xiexintangdrug-containing intestinal absorption solutiontumor-associated bone marrow mesenchymal stem cellscell crosstalk
《中国实验方剂学杂志》 2026 (20)
84-93,10
国家自然科学基金项目(82560910)甘肃省中医方药挖掘与创新转化重点实验室开放基金项目(FYWJ-24-05)甘肃省中药新产品工程实验室开放基金项目(ZYXCP-24-06)甘肃中医药大学科学研究与创新基金项目(2023KCYB-1)
评论